What are the NCCN and ESMO guidelines for long-term follow-up following complete remission of Hodgkin lymphoma?

Updated: Sep 12, 2018
  • Author: Bradley W Lash, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print

Both the National Comprehensive Cancer Network [4] and the European Society for Medical Oncology (ESMO) [5] guidelines provide recommendations for the long-term follow-up of treated patients with Hodgkin lymphoma who are in complete remission. [4, 5] Most relapses occur in the first 3 years after therapy, and Hodgkin lymphoma is the main cause of mortality in the first 10-15 years of follow-up. [110] Follow-up visits are recommended every 2-4 months for the first 1-2 years and every 3-6 months for the next 3-5 years.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!